SIH Partners, L »

Trevi Therapeutics shares owned by SIH Partners, L

Quarter-by-quarter ownership of Trevi Therapeutics (TRVI) shares owned by SIH Partners, L from 13F filings

Historical chart of SIH Partners, L investment in Trevi Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Trevi Therapeutics held by SIH Partners, L consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Trevi Therapeutics by SIH Partners, L

Quarter filed Position value Share count Share price at filing
2026-03-31 $119k 10k 11.93

More positions owned by SIH Partners, L

Totalenergies Se Act (TTE)
Ubs Group SHS (UBS)
Stellantis SHS (STLA)
Ferrari Nv Ord (RACE)
Alibaba Group Hldg Sponsored Ads (BABA)
Deutsche Bk Namen Akt (DB)
Alcon Ord Shs (ALC)
Logitech Intl S A SHS (LOGI)
Astrazeneca Ord (AZN)
Ishares Tr Msci Emg Mkt Etf (EEM)
Ishares Msci Sth Kor Etf (EWY)
Bhp Billiton Sponsored Ads (BHP)
Ishares Tr China Lg-cap Etf (FXI)
Jd.com Spon Ads Cl A (JD)
Kraneshares Trust Csi Chi Internet (KWEB)

View all positions for SIH Partners, L

Top funds holding Trevi Therapeutics

NEA Management Company
BlackRock
Frazier Life Sciences Management
FMR
Wellington Management Company
Vivo Capital
Vanguard Capital Management
Marshall Wace
Rubric Capital Management
MPM Oncology Impact Management
Viking Global Investors
Alliancebernstein
Geode Capital Management
State Street Corporation
Eventide Asset Management

View all funds holding Trevi Therapeutics